MEDICUS PHARMA LTD. (MDCX) earnings per share
Annual history
Fiscal years 2024 – 2025
USD / SHARE 3 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-12-31 | -$137.00 | 2026-03-25 |
| FY 2024 | 2024-12-31 | -$58.00 | 2025-03-28 |
| FY 2024 | 2023-12-31 | -$76.50 | 2025-03-28 |
Quarterly history
Fiscal years 2024 – 2026
USD / SHARE 10 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$10.50 | 2026-08-12 |
| Q1 2026 | 2026-03-31 | -$15.50 | 2026-05-14 |
| Q4 2025 | 2025-12-31 | -$41.50 | 2026-03-25 |
| Q3 2025 | 2025-09-30 | -$56.00 | 2025-11-14 |
| Q2 2025 | 2025-06-30 | -$21.50 | 2025-08-11 |
| Q1 2025 | 2025-03-31 | -$21.00 | 2025-05-12 |
| Q4 2024 | 2024-12-31 | -$16.00 | 2025-03-28 |
| Q3 2025 | 2024-09-30 | -$12.00 | 2025-11-14 |
| Q2 2025 | 2024-06-30 | -$22.00 | 2025-08-11 |
| Q1 2025 | 2024-03-31 | -$10.50 | 2025-05-12 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (2 split s since 2024).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
MDCX CIK 0001997296 Source: EDGAR filings · all facts